Peptide Encyclopedia / PEG-MGF
EncyclopediaPEG-MGF is a PEGylated form of the MGF E-peptide, the PEG chain slowing its clearance to extend time in circulation and action on muscle satellite cells. Evidence comes from animal and anecdotal reports, not human trials, and it stays unapproved and sold as a research chemical. Educational only, not medical advice.
| Category | Growth Hormone |
| Regulatory status | Not FDA-approved. |
A PEGylated (polyethylene-glycol-conjugated) version of the MGF E-peptide; the PEG moiety slows renal clearance and proteolysis, extending circulation time while the peptide is intended to act on muscle satellite cells as with MGF.
PEGylation is reported to extend the half-life from minutes (native MGF) to several hours; precise human values are not well established. It is a PEGylated peptide.
Not FDA-approved. Sold as a research chemical / for laboratory use only. Falls under IGF-1-related substances prohibited by WADA.
Same theoretical growth-signaling concerns as MGF/IGF-1, plus limited data on long-term effects of repeated PEGylated-peptide exposure. Research-grade purity is a practical concern.
Preclinical/animal and anecdotal only; no robust human clinical trials.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. PEG-MGF may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.